Baxter International Inc to acquire Chatham Therapeutics


Wednesday, 2 Apr 2014 09:00am EDT 

Baxter International Inc:Agreed to acquire all Chatham's outstanding membership interests.Baxter will acquire Chatham's developmental gene therapy programs directed toward development and commercialization of treatments for hemophilia. 

Company Quote

68.55
0.53 +0.78%
27 Mar 2015